Salta al contenuto principale
Home

Farmacovigilanza

Chiesi Farmaceutici ha un sistema di farmacovigilanza per assumersi la responsabilità dei nostri prodotti medicinali (sia quelli in commercio che in sviluppo clinico) e intraprendere azioni appropriate quando necessario. Ci assicuriamo che tutte le informazioni rilevanti per il rapporto tra benefici e rischi dei nostri prodotti medicinali siano valutate continuamente. Quando sorgono questioni importanti sulla sicurezza, se applicabile, notifichiamo tempestivamente ai professionisti sanitari, ai pazienti e alle autorità regolatorie interessate in conformità con la legislazione vigente.

Cos'è la farmacovigilanza? 

La farmacovigilanza è la scienza e le attività relative alla rilevazione, valutazione, comprensione e prevenzione degli effetti avversi o di qualsiasi altro problema correlato ai medicinali (Rif. Organizzazione Mondiale della Sanità, OMS. L'importanza della farmacovigilanza: monitoraggio della sicurezza dei prodotti medicinali, Ginevra, OMS, 2002). 

In linea con questa definizione generale, gli obiettivi principali della farmacovigilanza in conformità con la legislazione UE applicabile sono: prevenire danni da reazioni avverse negli esseri umani; promuovere l'uso sicuro ed efficace dei medicinali, in particolare fornendo informazioni tempestive sulla sicurezza dei medicinali ai pazienti, ai professionisti sanitari e al pubblico. 

La farmacovigilanza è quindi un'attività che contribuisce alla protezione della salute dei pazienti e del pubblico. 

Cos'è una reazione avversa da farmaco? 

Una risposta a un prodotto medicinale che è dannosa e non intenzionale (in questo contesto, "risposta" significa che esiste almeno una ragionevole possibilità di una relazione causale tra un prodotto medicinale e un evento avverso). 
Le reazioni avverse possono derivare dall'uso del prodotto all'interno o al di fuori dei termini dell'autorizzazione all'immissione in commercio o dall'esposizione professionale. Le condizioni di uso al di fuori dell'autorizzazione all'immissione in commercio includono l'uso fuori etichetta, sovradosaggio, uso improprio, abuso ed errori nella somministrazione. 

Cos'è la materiovigilanza? 

La Vigilanza sui Dispositivi Medici (materiovigilanza) è un sistema mirato a monitorare ed valutare gli incidenti legati ai dispositivi medici. Il Sistema di Vigilanza sui Dispositivi Medici mira a migliorare la protezione della salute e della sicurezza dei pazienti, dei professionisti sanitari e di altri utilizzatori riducendo la probabilità di ricorrenza di incidenti legati all'uso di un dispositivo medico. 

Cos'è un incidente o un evento sfavorevole legato a un dispositivo medico? 

Il termine "incidente" nella Regolamentazione dei Dispositivi Medici (UE) 2017/745 significa qualsiasi malfunzionamento o deterioramento delle caratteristiche o delle prestazioni di un dispositivo messo a disposizione sul mercato, compresi gli errori d'uso dovuti alle caratteristiche ergonomiche, nonché qualsiasi inadeguatezza delle informazioni fornite dal produttore e qualsiasi effetto indesiderabile.  

Informazioni su come segnalare una reazione avversa da farmaco o un incidente con un dispositivo medico 

Ogni paese ha le proprie leggi nazionali che disciplinano la segnalazione delle reazioni avverse da farmaco o degli incidenti con dispositivi medici. Pazienti e professionisti sanitari dovrebbero fare riferimento alle normative nazionali per la segnalazione.  

Avete la possibilità di segnalare direttamente al Titolare dell'Autorizzazione all'Immissione in Commercio (MAH) del farmaco che si sospetta abbia causato la reazione avversa o al Produttore del dispositivo medico che potrebbe aver causato l'incidente. 

Se desiderate notificarlo direttamente a Chiesi, vi preghiamo di inserire il paese in cui si è verificato l'evento nel campo appropriato e utilizzare i dettagli di contatto forniti. 

Paese in cui si è verificato l'evento/l'incidente:

Afghanistan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Albania

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Algeria

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Andorra

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Angola

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Antigua e Barbuda

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Arabia Saudita

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Argentina

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Armenia

Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11

Australia

Email: pv.au@chiesi.com

For medicinal drugs Birch bark extract, Lomitapide, Metreleptine and Octreotide acetate: cds@chiesi.com

Austria

Email: medinfo.at@chiesi.com
Tel: +43 1 407 39 19 - 0
Fax: +43 1 407 39 19 - 99018
Note: al di fuori del normale orario di lavoro: +43 676 88 555 518

Azerbaijan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bahamas

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bahrain

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bangladesh

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Barbados

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Belgio

Email: pv.benelux@chiesi.com
Tel: +32 (0)2 788 42 00

Belize

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Benin

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Bhutan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bielorussia

Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11

Bolivia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bosnia e Erzegovina

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Botswana

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Brasile

Email: farmacovigilancia.br@chiesi.com

Brunei

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Bulgaria

Email: office.bg@chiesi.com
Tel: +359 2 920 12 05
Note: Tel. (disponibilità 24h): +359 885 150 578

Per i farmaci Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa and Velmanase alfa: cds@chiesi.com

Burkina Faso

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Burundi

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Cambogia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Camerun

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Canada

Email: cds@chiesi.com
Note: Per il farmaco Ferriprox: ca.pharmacovigilance@chiesi.com 1-800-854-3534

Capo Verde 

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Ciad

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Cile

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Cina

Email: drugsafety.cn@chiesi.com
Tel: +86 18616354367

Cipro

Email: pharmacovigilance.gr@chiesi.com
Tel: :+30 210 6179763
Fax: +30 210 6179787

Per i farmaci Birch bark estratto, Deferiprone, Lomitapide, Metreleptina: cds@chiesi.com

Colombia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Comore

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Costa d'Avorio

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Costa Rica

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Croazia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Cuba

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Danimarca

Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20

Dominica

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Ecuador

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Egitto

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

El Salvador

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Emirati Arabi Uniti

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Eritrea

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Estonia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Eswatini

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Etiopia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Figi

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Filippine

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Finlandia

Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20

Francia

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
 

Gabon

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Gambia

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Georgia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Germania

Email: DE-AMS@chiesi.com
Fax: +49 (0)40 897 24-270
 

Ghana

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Giamaica

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Giappone

Email: pv.japan@chiesi.com
Tel: +81 120 484648

Gibuti

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Giordania

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Grecia

Email: pharmacovigilance.gr@chiesi.com
Tel:+30 210 6179763
Fax: +30 210 6179786

Per i farmaci Birch bark estratto, Deferiprone, Lomitapide, Metreleptina: cds@chiesi.com

Grenada

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Guatemala

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Guinea

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
 

Guinea Equatoriale

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Guinea-Bissau

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Guyana

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Haiti

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Honduras

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Hong Kong

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

India

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Indonesia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Iran

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Iraq

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Irlanda

Email: pv.uk@chiesi.com
Tel: 1800 817459
Note: Il numero gratuito per l'Irlanda è funzionante solo se si chiama dall'interno dell'Irlanda. Non funzionante dall'estero.

Islanda

Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20

Isole Cook

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Isole Marshall

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Isole Salomone

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Israele

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Italia

Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791

Kazakistan

Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11

Kenya

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Kirghizistan

Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11

Kiribati

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Kosovo

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Kuwait

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Laos

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Lesotho

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Lettonia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Libano

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Liberia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Libia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Liechtenstein

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Lituania

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Lussemburgo

Email: pv.benelux@chiesi.com
Tel: +32 (0)2 788 42 00

Macedonia del Nord

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Madagascar

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Malawi

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Maldive

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Malesia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Mali

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Malta

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Marocco

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Mauritania

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Mauritius

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Messico

Email: farmacovigilancia.mx@chiesi.com
Tel: 800 200 02 60
Mobile: +56 199 99 227

For medicinal drugs Birch bark extract, Lomitapide, Metreleptine and Octreotide acetate: cds@chiesi.com

Moldavia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Monaco

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax: +33 1 47 68 48 08
 

Mongolia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Montenegro

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Mozambico

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Myanmar

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Namibia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Nauru

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Nepal

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Nicaragua

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Niger

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Nigeria

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Norvegia

Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20

Nuova Zelanda

Email: pv.au@chiesi.com

Oman

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Paesi Bassi

Email: pv.benelux@chiesi.com
Tel: +31 (0)88 501 64 00

Pakistan

Email: Pv.pk@chiesi.com
Tel: +92-3458407000
Fax: +92-42-111244374

Per i farmaci Birch bark estratto, Lomitapide, Metreleptina e Octreotide acetato: cds@chiesi.com

Palau

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Palestina

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Panama

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Papua Nuova Guinea

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Paraguay

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Perù

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Polonia

Email: apvpl@chiesi.com
Tel: +48 22 620 14 21
Fax: +48 22 652 37 79

Per i farmaci Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa e Velmanase alfa: cds@chiesi.com

Portogallo

Email: safety@pharmaffairs.com
Tel: +351 21 124 6807

Qatar

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Regno Unito

Email: pv.uk@chiesi.com
Tel: +44 (0)800 0092329

Repubblica Ceca

Email: safety.cz@chiesi.com
Tel: +420 261 211 850
Fax: +420 261 221 767

Per i farmaci Birch bark estratto, Lomitapide, Metreleptina: cds@chiesi.com
 

Repubblica Centroafricana

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com 

Repubblica Democratica del Congo

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Repubblica Democratica Popolare di Corea (Corea del Nord)

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com 

Repubblica di Corea (Corea del Sud)

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com 

Repubblica Domenicana

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com 

Romania

Email: medinfo.ro@chiesi.com
Tel: +40212023642
Fax: +40212023643

For medicinal drugs Birch bark extract, Lomitapide, Metreleptine: cds@chiesi.com

Ruanda

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Russia

Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11

Saint Kitts e Nevis

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Saint Vincent e Grenadine

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Samoa

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

San Marino

Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791

Santa Lucia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Senegal

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Serbia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Seychelles 

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Sierra Leone

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Singapore 

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Siria

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Slovacchia

Email: pharmacovigilance.sk@chiesi.com


Per i farmaci Birch bark estratto, Lomitapide, Metreleptina: cds@chiesi.com

Slovenia

Email: farmakovigilanca.si@chiesi.com


Per i farmaci Birch bark estratto, Lomitapide, Metreleptina: cds@chiesi.com
 

Somalia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Spagna

Email: farmacovigilancia@chiesi.com
Tel: +34 93 494 80 00

Sri Lanka

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Stati Uniti d'America

Email: us.medical@chiesi.com
Tel: 1-888-661-9260
Fax: 1-866-443-3092

Sud Africa

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Sud Sudan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Sudan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Suriname

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Svezia

Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
 

Svizzera

Email: chiesisa_pv@ompharma.com
Tel: +41 22 783 14 44
Fax: +41 22 783 16 01

Per i medicinali: Lomitapide e Metreleptina: cds@chiesi.com

São Tomé and Príncipe

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Tagikistan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Taiwan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Tanzania

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Thailandia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Timor-Leste

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Togo

Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08

Tonga

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Trinidad e Tobago

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Tunisia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Turchia

Email: info.tr@chiesi.com
Tel: +90 212 370 91 00
Fax: +90 212 370 91 27

Per i farmaci Birch bark estratto, Lomitapide, Metreleptina, Octreotide acetato e Velmenase alfa: cds@chiesi.com

Turkmenistan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Tuvalu

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Ucraina

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Uganda

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Ungheria

Email: mellekhatas@chiesi.com
Tel: +36 1 429 1060Fax: +36 1 429 1064

Per i farmaci Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa e Velmanase alfa: cds@chiesi.com

Uruguay

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Uzbekistan

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Vanuatu

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Vaticano

Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791

Venezuela

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Vietnam

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Yemen

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Zambia

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com

Zimbabwe

Adverse Drug Reaction with medicinal product:
cds@chiesi.com

Incident with Medical Device:
MDchiesi@chiesi.com